|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/21 | |
| A61K 31/167 | |||
| A61K 31/18 | |||
| A61K 31/395 | |||
| A61P 31/20 |
| (11) | Patento numeris | 3102225 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15746664.0 |
| Europos patento paraiškos padavimo data | 2015-02-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/014663 |
| Data | 2015-02-05 |
| (87) | Numeris | WO 2015/120178 |
| Data | 2015-08-13 |
| (30) | Numeris | Data | Šalis |
| 201461936242 P | 2014-02-05 | US |
| (72) |
HARTMAN, George D., US
|
| (73) |
Novira Therapeutics Inc.,
Welsh & McKean Roads Mailstop SH 22-2-1, Spring House PA 19477,
US
|
| (54) | COMBINATION THERAPY FOR TREATMENT OF HBV INFECTIONS |
| COMBINATION THERAPY FOR TREATMENT OF HBV INFECTIONS |